drug design and development Flashcards
what is a drug?
a chemical substance of known structure which produces a biological effect when administered
what are the requirements for a drug?
- soluble in water and fat
- cell penetrable
- potent
- selective
what are Lipinski’s rule of 5?
a compound is more likely to be absorbed if:
1) molecular weight below 500g/mol
2) low lipophilicity logP<5
3) fewer than five H-bond donor atoms
4) fewer than 10 H-bond acceptor atoms
5) level of ionisation compared to environment
what is the druggable proteome?
the fraction of proteins which have the ability to bind a small molecule with the required affinity and appropriate chemical properties, and at the same time are potential drug targets that are linked to a disease
outline the drug development process
1) drug discovery: during which candidate molecules are chosen on the basis of their pharmacological properties
2) pre-clinical development: during which a wide range of non-human studies including toxicity testing, pharmacokinetic analysis and formulation are performed
3) clinical development: during which the selected compound is tested for efficacy, side effects and potential dangers
how are targets identified in infectious disease?
target a protein known for growth/reproduction, must be unique to host or have detailed structural differences. perform genome analysis
how are targets identified in genetic disease?
target is endogenous, extensive knowledge of cellular, molecular, and biochemical details of the disease are required. genome analysis required
explain how a target in E.coli could be found
sequence: model E.coli genome has 4289 genes
spectrum: 246 genes conserved with humans
comparison with human sequences: 68 not the same as found in humans
loss of function tests: identifes 18 essential genes, 16 non-essential, 34 unknown
explain how a target for malaria could be found
sequence: genome has 5,300 genes in 14 chromosomes
function of proteins (knockout): 2/3 genes responsible for growth, identifies essential parasite genes and pathways for drug-target prioritisation
comparison with human proteins: 60% unique to parasite